Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041889 | SCV000065585 | likely benign | not specified | 2011-09-25 | criteria provided, single submitter | clinical testing | Ser2170Arg in exon 34 of USH2A: This variant is not expected to have clinical si gnificance because the Serine 2170 residue is poorly conserved in mammals with m ost other species having an Asparagine. Therefore, this variant is likely benign . |
Eurofins Ntd Llc |
RCV000041889 | SCV000343285 | benign | not specified | 2016-07-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000923504 | SCV001068984 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000923504 | SCV001842099 | benign | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450876 | SCV004181656 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001826598 | SCV004181657 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826598 | SCV002090885 | benign | Usher syndrome type 2A | 2020-08-18 | no assertion criteria provided | clinical testing |